优先审评券：促进被忽视疾病药物研发的低效且危险的方式。 - Suppr

Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.

作者信息

Kesselheim A S

机构信息

Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Clin Pharmacol Ther. 2009 Jun;85(6):573-5. doi: 10.1038/clpt.2009.50.

DOI:10.1038/clpt.2009.50

PMID:19451908

Abstract

摘要

相似文献

Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.

Clin Pharmacol Ther. 2009 Jun;85(6):573-5. doi: 10.1038/clpt.2009.50.

Drug and vaccine development for infectious diseases: the value of priority review vouchers.

Clin Pharmacol Ther. 2009 Jun;85(6):571-2. doi: 10.1038/clpt.2009.53.

Promoting, improving and accelerating the drug development and approval processes.

Drug News Perspect. 2009 Jan-Feb;22(1):30-8. doi: 10.1358/dnp.2009.22.1.1303816.

Biodefense. Critics question proposed countermeasures agency.

Science. 2005 Nov 4;310(5749):755. doi: 10.1126/science.310.5749.755.

Concerns raised over declining antiinfectives R&D.

Nat Biotechnol. 2003 Nov;21(11):1255-6. doi: 10.1038/nbt904.

Biodefense. House passes plan for drug, vaccine R&D.

Science. 2006 Oct 6;314(5796):39. doi: 10.1126/science.314.5796.39b.

FDA launches priority vouchers for neglected-disease drugs.

Nat Biotechnol. 2008 Dec;26(12):1315-6. doi: 10.1038/nbt1208-1315.

A critical tipping point.

US News World Rep. 2002 Apr 22;132(13):72.

Developing drugs for developing countries.

Health Aff (Millwood). 2006 Mar-Apr;25(2):313-24. doi: 10.1377/hlthaff.25.2.313.

An uncertain call to arms.

Science. 2004 Apr 16;304(5669):359. doi: 10.1126/science.304.5669.359.

引用本文的文献

Priorities for the Priority Review Voucher.

Am J Trop Med Hyg. 2017 Jan 11;96(1):14-15. doi: 10.4269/ajtmh.16-0600. Epub 2016 Aug 29.

New regulatory paradigms for innovative drugs to treat pediatric diseases.

JAMA Pediatr. 2014 Oct;168(10):879-80. doi: 10.1001/jamapediatrics.2014.904.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.

Clin Pharmacol Ther. 2009 Jun;85(6):573-5. doi: 10.1038/clpt.2009.50.

Drug and vaccine development for infectious diseases: the value of priority review vouchers.

Clin Pharmacol Ther. 2009 Jun;85(6):571-2. doi: 10.1038/clpt.2009.53.

Promoting, improving and accelerating the drug development and approval processes.

Drug News Perspect. 2009 Jan-Feb;22(1):30-8. doi: 10.1358/dnp.2009.22.1.1303816.

Biodefense. Critics question proposed countermeasures agency.

Science. 2005 Nov 4;310(5749):755. doi: 10.1126/science.310.5749.755.

Concerns raised over declining antiinfectives R&D.

Nat Biotechnol. 2003 Nov;21(11):1255-6. doi: 10.1038/nbt904.

Biodefense. House passes plan for drug, vaccine R&D.

Science. 2006 Oct 6;314(5796):39. doi: 10.1126/science.314.5796.39b.

FDA launches priority vouchers for neglected-disease drugs.

Nat Biotechnol. 2008 Dec;26(12):1315-6. doi: 10.1038/nbt1208-1315.

A critical tipping point.

US News World Rep. 2002 Apr 22;132(13):72.

Developing drugs for developing countries.

Health Aff (Millwood). 2006 Mar-Apr;25(2):313-24. doi: 10.1377/hlthaff.25.2.313.

An uncertain call to arms.

Science. 2004 Apr 16;304(5669):359. doi: 10.1126/science.304.5669.359.

引用本文的文献

Priorities for the Priority Review Voucher.

Am J Trop Med Hyg. 2017 Jan 11;96(1):14-15. doi: 10.4269/ajtmh.16-0600. Epub 2016 Aug 29.

New regulatory paradigms for innovative drugs to treat pediatric diseases.

JAMA Pediatr. 2014 Oct;168(10):879-80. doi: 10.1001/jamapediatrics.2014.904.

Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.

作者信息

机构信息

出版信息

相似文献

引用本文的文献